RANIBIZUMAB-EQRN | B761165 | SANDOZ INC
Regulatory Exclusivities
| Type | Expiry | Status | Source |
|---|---|---|---|
| 12-Year BPCIA | Aug. 2, 2034 | Active | Computed |
| 1-Year Interchangeable | Oct. 3, 2023 | Expired | Purple Book |
Purple Book Patents
No listed patents in Purple Book.
Estimated Patent LOE
Based on latest discovered patent 12371510(manufacturing) · relevance 75/100
Estimate based on AI-discovered patents. No patents are officially listed in the Purple Book for this product.
Approved Biosimilars
Top 50 of 230 AI-discovered patents by relevance.
No patent or exclusivity listings for this strength.